GlassScriptPhysician profile
Tiffany D Leister
NPI 1629302823
$10,766.52
in general payments reported to CMS, 2019-2025
39 companies · $2,923 in 2025
The $2,923 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,002 · 2022: $1,925 · 2023: $2,347 · 2024: $2,570 · 2025: $2,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,744 · Education: $96.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,743.66 |
| Education | $96.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,022.06 | 2021-2025 | Aveir, Jot Dx, Confirm Rx |
| Philips North America LLC | $933.98 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, Mcot |
| Pfizer INC. | $875.60 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $839.29 | 2021-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $745.65 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $615.08 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $561.12 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $486.92 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $471.79 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $463.38 | 2021-2025 | Wainua, Farxiga, Airsupra |
| Boston Scientific Corporation | $454.04 | 2021-2025 | Watchman Flx |
| Novo Nordisk INC | $438.56 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $429.77 | 2021-2024 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Corevalve Evolut R |
| Bayer Healthcare Pharmaceuticals INC. | $425.10 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.78 | 2021-2025 | Jardiance |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $234.69 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $219.40 | 2025 | Amvuttra |
| Irhythm Technologies, INC. | $210.84 | 2022-2023 | Zio Xt Patch |
| Edwards Lifesciences Corporation | $177.24 | 2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Esperion Therapeutics, INC. | $122.68 | 2021-2025 | Nexletol |
| Impulse Dynamics (USA) INC. | $107.77 | 2022-2023 | Optimizer |
| Viiv Healthcare Company | $93.67 | 2024 | |
| Inspire Medical Systems, INC. | $91.51 | 2025 | Inspire |
| Gilead Sciences, INC. | $69.87 | 2024 | Epclusa |
| Lexicon Pharmaceuticals, INC. | $44.26 | 2023-2024 | Inpefa |
| Angiodynamics, INC. | $43.28 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Bridgebio Pharma, INC. | $41.96 | 2025 | Attruby |
| Amarin Pharma, INC. | $41.19 | 2021 | |
| Cvrx, INC. | $33.92 | 2022-2025 | Barostim Neo System |
| Astellas Pharma US INC | $32.42 | 2022 | |
| Abiomed | $30.65 | 2025 | |
| Silk Road Medical, INC. | $20.37 | 2021 | |
| Atricure, INC. | $18.81 | 2023 | |
| Heartflow, INC. | $17.32 | 2024 | |
| Vifor Pharma, INC. | $17.03 | 2021 | |
| Scpharmaceuticals INC. | $16.81 | 2024 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.23 | 2021 | |
| Genentech USA, INC. | $4.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Leister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.